All News

    Eflornithine Plus Gleostine Improves Progression, Survival In Some With Astrocytoma

    November 23rd 2025, 2:00pm

    Article

    Eflornithine plus Gleostine was associated with superior overall survival and progression-free survival in grade 3 IDH-mutated astrocytoma.

    B7-H3 CAR T-Cell Therapy Shows Acceptable Safety in Recurrent Glioblastoma

    November 22nd 2025, 3:55pm

    Article

    Intraventricular B7-H3 CAR T-cell therapy was well tolerated up to 1 x 10⁷ cells per infusion and showed early signs of activity in recurrent glioblastoma.

    Voranigo Plus Temodar Found to Be Safe in Patients With IDH1/2+ Glioma

    November 22nd 2025, 3:45pm

    Article

    Voranigo plus Temodar was safe in glioma with IDH1/2 mutations.

    Gomekli Shows Early Activity in Pediatric Low Grade Glioma

    November 22nd 2025, 2:10pm

    Article

    Early data from the SJ901 study show Gomekli generates responses with manageable side effects in children and young adults with low grade glioma.

    Early Real-World Uptake of Voranigo in Patients With IDH-Mutant Glioma

    November 21st 2025, 10:55pm

    Article

    Early data indicate Voranigo is rapidly being used in newly diagnosed and previously treated patients with IDH-mutant glioma, highlighting ongoing treatment needs.

    Effective Early Treatments Needed in Glioma, Real-World Data Finds

    November 21st 2025, 10:30pm

    Article

    Researchers identified a potential unmet need for an effective early treatment with minimal toxicity for patients with slow-growing IDH-mutant gliomas.

    FDA Approves Keytruda and Padcev for Muscle Invasive Bladder Cancer

    November 21st 2025, 5:49pm

    Article

    Keytruda and Padcev improve event-free and overall survival for adults with muscle invasive bladder cancer who cannot receive cisplatin after surgery.

    Patient Advocate Shares Why The Future Is Bright For PV

    November 21st 2025, 5:00pm

    Article

    In a recent interview with CURE, Nona Baker shared insights from her blood cancer journey that began more than 30 years ago.

    Giredestrant Shows Benefit for Early Breast Cancer in Phase 3 Trial

    November 21st 2025, 4:00pm

    Article

    Giredestrant improved invasive disease-free survival for people with estrogen receptor-positive early breast cancer compared with standard treatment.

    Finding Grace in the Nurses Who Helped My Daughter Through Treatment

    November 21st 2025, 2:29pm

    Article

    I share how the nurses who cared for my daughter during chemotherapy brought comfort, connection and humanity that carried us through our hardest moments.